Showing results (81-90 of 323) with videos related to
Sort By:
Pageof 33
Archives of Biochemistry and Biophysics|July 15, 1983
Effects of acetylation and guanidination on alkaline conformations of chymotrypsinA T Fojo, P L Whitney, W M AwadHospital Practice (Office Ed.)|April 15, 1990
Multidrug resistance due to P-glycoproteinR K Burt, A T Fojo, S S ThorgeirssonCancer|October 1, 1975
Ectopic placental proteins in nontrophoblastic tumors. Serial measurements following chemotherapyF M Muggia, S W Rosen, B D Weintraub, et al.Anticancer Research|May 1, 1991
High dose intensity of cisplatin and etoposide in adenocarcinoma of unknown primaryI Gill, P Guaglianone, S M Grunberg, et al.Archiv Fur Geschwulstforschung|January 1, 1978
Effective adjuvant treatments. A brief review of U.S. clinical trialsA C Louie, M Rozencweig, D D von Hoff, et al.Journal of Neuro-Oncology|June 1, 1990
Plasma carcinoembryonic antigen as an indicator of cerebral metastasesE A Eden, J M Muggia, E M Hiesiger, et al.Cancer Chemotherapy and Pharmacology|January 1, 1979
m-AMSA and PALA: two new agents in cancer chemotherapyM Rozencweig, D D Von Hoff, R L Cysyk, et al.Cancer Treatment Reports|June 1, 1979
Azaserine, DON, and azotomycin: three diazo analogs of L-glutamine with clinical antitumor activityR Catane, D D Von Hoff, D L Glaubiger, et al.Biochemical and Biophysical Research Communications|March 26, 1998
Like p53, the proliferation-associated protein p120 accumulates in human cancer cells following exposure to anticancer drugsM V Blagosklonny, A Iglesias, Z Zhan, et al.Oncogene|July 6, 2001
Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicityP Giannakakou, R Robey, T Fojo, et al.Pageof 33